首页 | 本学科首页   官方微博 | 高级检索  
     

长链非编码RNA-PVT1介导JAK/STAT3信号通路对肺纤维化的研究
引用本文:卓超洲,沈观乐,雷朝君,余瑞林,梁杰,高妩媚,魏艾. 长链非编码RNA-PVT1介导JAK/STAT3信号通路对肺纤维化的研究[J]. 新医学, 2022, 53(7): 496-502. DOI: 10.3969/j.issn.0253-9802.2022.07.007
作者姓名:卓超洲  沈观乐  雷朝君  余瑞林  梁杰  高妩媚  魏艾
作者单位:518109 深圳,深圳市龙华区人民医院呼吸内科
基金项目:深圳市基础研究资助项目(JCYJ20180228164139811)
摘    要:目的 探讨长链非编码RNA-浆细胞瘤变异易位基因1/蛋白质酪氨酸激酶/信号转导和转录激活因子3(lnc-PVT1/JAK/STAT3)信号通路参与肺纤维化的作用机制。方法 采用不同浓度脂多糖(LPS)作用于人正常肺上皮细胞BEAS-2B,用CCK-8法检测细胞活性、蛋白免疫印迹法检测α-SMA的蛋白相对表达量,对LPS...

关 键 词:浆细胞瘤变异易位基因1  肺纤维化  蛋白质酪氨酸激酶/信号转导和转录激活因子3  炎症因子
收稿时间:2022-02-25

Long non-coding RNA-PVT1 induces the progression of pulmonary fibrosis via the JAK/STAT3 signaling pathway
Zhuo Chaozhou,Shen Guanle,Lei Chaojun,Yu Ruilin,Liang Jie,Gao Wumei,Wei Ai. Long non-coding RNA-PVT1 induces the progression of pulmonary fibrosis via the JAK/STAT3 signaling pathway[J]. New Chinese Medicine, 2022, 53(7): 496-502. DOI: 10.3969/j.issn.0253-9802.2022.07.007
Authors:Zhuo Chaozhou  Shen Guanle  Lei Chaojun  Yu Ruilin  Liang Jie  Gao Wumei  Wei Ai
Affiliation:Department of Respiratory Medicine, Shenzhen Longhua District People’s Hospital, Shenzhen 518109, China
Abstract:Objective To investigate the role of long non-coding RNA-PVT1/JAK/STAT3 signaling pathway in pulmonary fibrosis. Methods BEAS-2B cells were treated with different concentrations of LPS. Cell viability was assessed by CCK-8. The relative expression level of α-SMA protein was determined by western blot. The concentration of LPS was screened. BEAS-2B cells were treated with the optimal concentration of LPS to establish the pulmonary fibrosis model in vitro. BEAS-2B cells were transiently transfected with lnc-PVT1 siRNA and control siRNA followed by LPS treatment. The expression level of lnc-PVT1 was determined by RT-qPCR. Effective inhibitory targets were selected for subsequent experiment. BEAS-2B cells were divided into the control (Con)group, LPS group, LPS+siRNA control (LPS+siNC) group and LPS+siPVT1 group. After transiently transfected with siPVT1 and siRNA control, BEAS-2B cells were treated with 10μg/mL LPS for 24 h. Cell viability was assessed by CCK-8. Cell migration was evaluated by cell scratch test. The relative expression level of lnc-PVT1 mRNA was measured by RT-qPCR. The expression levels of IL-6,IL-1β and TNF-α in the cultured supernatant were measured by ELISA. The expression levels of α-SMA, STAT3 and p-STAT3 were assessed by western blot. Results In the LPS group treated with 10 μg/mL LPS for 24 h, the cell proliferation was significantly higher and the expression level of fibrotic marker α-SMA protein was remarkably up-regulated than those in the Con group (both P < 0.01). Compared with the LPS group, knockdown of lnc-PVT1 could significantly inhibit the cell proliferation and migration induced by LPS (both P < 0.01), down-regulate the expression levels of IL-6, IL-1β and TNF-α (all P < 0.01), and decrease the expression levels of α-SMA mRNA and protein as well as the phosphorylated STAT3 protein (all P < 0.01). However, the relative expression level of total STAT3 protein was not affected. Conclusion Knockdown of lnc-PVT1 can effectively attenuate the LPS-induced BEAS-2B cell fibrosis, which may be associated with the role of lnc-PVT1 in regulating the JAK/STAT3 signaling pathway.
Keywords:lnc-PVT1  Pulmonary fibrosis  JAK/STAT3  Inflammatory cytokine  
点击此处可从《新医学》浏览原始摘要信息
点击此处可从《新医学》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号